Cubist Systematic Strategies’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,172
Closed -$37K 3431
2025
Q2
$37K Buy
+1,172
New +$37.7K ﹤0.01% 2802
2024
Q2
Sell
-63,269
Closed -$2.12M 3552
2024
Q1
$2.12M Sell
63,269
-38,238
-38% -$1.23M 0.02% 1600
2023
Q4
$3.28M Buy
+101,507
New +$2.83M 0.04% 1130
2023
Q3
Sell
-85,633
Closed -$3.01M 3639
2023
Q2
$3.01M Buy
85,633
+39,862
+87% +$1.38M 0.03% 1171
2023
Q1
$1.49M Sell
45,771
-90,838
-66% -$4.14M 0.01% 1868
2022
Q4
$7.53M Buy
136,609
+52,223
+62% +$2.87M 0.06% 682
2022
Q3
$3.74M Buy
84,386
+60,069
+247% +$2.93M 0.03% 1361
2022
Q2
$1.19M Sell
24,317
-70,470
-74% -$3.17M 0.01% 2337
2022
Q1
$4.61M Buy
94,787
+51,787
+120% +$2.11M 0.04% 792
2021
Q4
$1.83M Sell
43,000
-11,633
-21% -$464K 0.02% 1450
2021
Q3
$2.09M Buy
54,633
+34,947
+178% +$1.13M 0.03% 980
2021
Q2
$556K Buy
+19,686
New +$591K 0.01% 1939

Other funds holding HRMY